» Articles » PMID: 12944488

Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of C-Myb

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2003 Aug 29
PMID 12944488
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The c-myb proto-oncogene encodes two alternatively spliced mRNAs, which in turn code for proteins of 75 kDa and 89 kDa. It is at present unclear whether the two isoforms of c-Myb perform identical functions or whether they mediate different biological effects. To assess their role in apoptotic death of hematopoietic cells, we expressed the two isoforms of c-Myb in the murine myeloid cell lines 32Dcl3 and FDCP1. Our results show that while ectopic overexpression of p75 c-Myb results in the acceleration of cell death, similar overexpression of p89 c-Myb results in the protection of cells from apoptotic death. An analysis of gene expression changes with mouse cDNA expression arrays revealed that while p75 c-Myb blocked the expression of glutathione S-transferase micro mRNA, p89 c-Myb greatly enhanced the expression of this gene. These results were further confirmed by Northern blot analysis. Ectopic overexpression of the glutathione S-transferase micro gene in 32Dcl3 cells resulted in protection of cells from interleukin-3 withdrawal-induced cell death similar to that seen with the ectopic overexpression of p89 c-Myb. These results suggest that the two isoforms of c-Myb differentially regulate apoptotic death of myeloid cells through differential regulation of glutathione S-transferase micro gene expression.

Citing Articles

Role of miRNAs in Apoptosis Pathways of Immune Cells in Systemic Lupus Erythematosus.

Azizan A, Farhadi E, Faezi S, Jamshidi A, Alikhani M, Mahmoudi M Immun Inflamm Dis. 2025; 13(2):e70124.

PMID: 39912562 PMC: 11800236. DOI: 10.1002/iid3.70124.


From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies.

Anand S, Vikramdeo K, Sudan S, Sharma A, Acharya S, Khan M Cancer Metastasis Rev. 2023; 43(1):409-421.

PMID: 37950087 PMC: 11015973. DOI: 10.1007/s10555-023-10153-8.


Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.

Zheng X, Peng Q, Wang L, Zhang X, Huang L, Wang J Int J Biol Sci. 2020; 16(13):2442-2453.

PMID: 32760211 PMC: 7378643. DOI: 10.7150/ijbs.46751.


Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.

Manzotti G, Mariani S, Corradini F, Bussolari R, Cesi V, Vergalli J Blood Cancer J. 2012; 2(5):e71.

PMID: 22829973 PMC: 3366069. DOI: 10.1038/bcj.2012.16.


Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.

Zhou Y, ORourke J, Edwards J, Ness S PLoS One. 2011; 6(8):e22880.

PMID: 21853052 PMC: 3154906. DOI: 10.1371/journal.pone.0022880.


References
1.
Frampton J, Ramqvist T, Graf T . v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 1996; 10(21):2720-31. DOI: 10.1101/gad.10.21.2720. View

2.
Taylor D, Badiani P, WESTON K . A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 1996; 10(21):2732-44. DOI: 10.1101/gad.10.21.2732. View

3.
Yang J, Liu X, Bhalla K, Kim C, Ibrado A, Cai J . Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997; 275(5303):1129-32. DOI: 10.1126/science.275.5303.1129. View

4.
Nomura T, Sakai N, Sarai A, Sudo T, Ramsay R, Favier D . Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem. 1993; 268(29):21914-23. View

5.
Kluck R, Bossy-Wetzel E, Green D, Newmeyer D . The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997; 275(5303):1132-6. DOI: 10.1126/science.275.5303.1132. View